July 31, 2026
avatar-torie-bosch
First Opinion editor

Lately, I’ve been craving a particular a type of op-ed: the “I was wrong” piece.

Back in June, an education policy expert who helped push No Child Left Behind wrote a guest essay in the New York Times about how he and colleagues got it wrong. “Over time, I became convinced that, with the best of intentions, I and many others in the education reform community had transferred our moral commitment to children over to the standardized tests. We had done this earnestly, not cynically, but we still did damage,” he wrote.

It's a shame that this type of op-ed is so rare, because I think it’s one of the most powerful types of persuasive writing. A headline that says “I was wrong” certainly catches the eye — but more importantly, this type of piece requires the writer to take the reader through their thought process, forcing them to address the strongest counterarguments.

Have you changed your mind about something? Perhaps you’re a physician who thought one thing, and then personal experience with a diagnosis taught you otherwise. Maybe, like the New York Times writer, you’re a policy expert who realized that what you advocated for didn’t work as intended or hoped. Or maybe you’re a biotech executive who thought AI would be transformative, then realized that it isn’t (yet?) the case.

Whatever it might be, I want to hear it. Send me your “I changed my mind” or “I got it wrong” submissions.

Recommendation of the week: The Cut takes a look at how sleepaway camp infirmaries have transformed as more and more kids show up on complicated regiments of prescriptions (including GLP1s) and supplements.



Adobe

The VA could help America win the biotechnology race with China

The VA isn’t just a health care delivery system —it’s critical biotechnology infrastructure capable of shortening drug development timelines.

By David Shulkin


We once praised the American Diabetes Association’s courage. How things have changed

Nine years ago, Adam Marcus and Ivan Oransky gave the American Diabetes Association their ‘Doing the Right Thing’ award. Things have changed at the ADA.

By Adam Marcus and Ivan Oransky


How midwives like me can help fight medical misinformation

Midwives excel at listening without judgment, honoring autonomy, and building trust over time — an advantage when fighting vaccine misinformation.

By Mara Evans


Adobe

Limb girdle muscular dystrophy patients face a maddening reality

As Congress considers FDA reforms to accompany reauthorization of the Prescription Drug User Fee Act, it should prioritize rare disease cures.

By Kat Bryant Knudson


Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases

Mycetoma, a neglected disease reported in more than 100 countries, has seen progress — but it’s fragile.

By Borna Nyaoke-Anoke


Prolonged hospital stays can leave children isolated. It needs to change

Children with prolonged hospitalizations often spend lengthy stretches of time alone, leading to long-term consequences.

By Anna Tsioulias


Mario Tama/Getty Images

E-bikes, e-scooters are a burgeoning pediatric public health emergency

High-speed e-bike and e-scooter accidents can create multiple traumas, with injury patterns that look akin to a child hit by a car.

By J. Todd R. Lawrence and Madison A. Kesler


STAT+ | Dementia finally has a business model

Breakthroughs in dementia care are creating a new economy of tests, drugs and risk calculators.

By Jason Karlawish


More around STAT

 
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.